Article content material
VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Xenon Prescription drugs Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical firm, at present introduced that the corporate will current on the forty second Annual J.P. Morgan Healthcare Convention happening in San Francisco, CA from January 8-11, 2024.
Firm Presentation Particulars:
Article content material
A stay audio webcast of the corporate presentation can be obtainable on the “Buyers” part of Xenon’s web site and posted for replay following the occasion. The above listed dates and instances are topic to alter.
About Xenon Prescription drugs Inc.
Xenon Prescription drugs (NASDAQ:XENE) is a medical stage biopharmaceutical firm dedicated to growing revolutionary therapeutics to enhance the lives of sufferers with neurological problems. We’re advancing a novel product pipeline of neurology therapies to deal with areas of excessive unmet medical want. For extra info, please go to www.xenon-pharma.com.
“Xenon” and the Xenon brand are registered emblems or emblems of Xenon Prescription drugs Inc. in varied jurisdictions. All different emblems belong to their respective proprietor.
Investor/Media Contact:
Jodi Regts
Xenon Prescription drugs Inc.
Cellphone: (604) 484-3353
E-mail: buyers@xenon-pharma.com
Share this text in your social community
Source link
